The Panther Fusion GBS assay is a real-time PCR assay to detect the gram-positive bacterium Streptococcus agalactiae (GBS) from antepartum women. It features world-class performance and sensitivity so providers can diagnose GBS confidently and take steps to reduce transmission to babies.1
When transmitted to babies during childbirth, GBS can lead to sepsis, pneumonia, meningitis and death.2 If GBS is diagnosed before birth, providers may administer antibiotic prophylaxis during delivery, which can reduce the chance of transmission. By using tests with excellent sensitivity and performance like the Panther Fusion GBS assay, providers can focus on providing the best-possible care.
The Panther Fusion GBS assay leverages the benefits of the Panther Fusion® system and growing menu of Aptima® and Panther Fusion® assays.